News
Institutional Review Board Approves Regenative Labs’ Protocol For Key Data Collection
Jul 08, 2022
Regenative Labs CEO predicts this will have significant implications to advance multiple fields. PENSACOLA, Fla., July 8, 2022 /PRNewswire/ —… Read More >
A Letter from the CEO
Jun 15, 2021
Regenative Labs to-date produces the first and only Wharton’s jelly allograft to be recognized as a 361 HCT/P by any… Read More >
Regenative Labs: Medicare Approval for Wharton’s Jelly Reimbursement
Aug 05, 2020
PENSACOLA, FLA. (PRWEB) AUGUST 05, 2020 Regenative Labs has received approval from the Centers for Medicare & Medicaid Services (CMS)… Read More >